JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB143594

Cholecalciferol (Vitamin D3), VDR activator

Be the first to review this product! Submit a review

|

(1 Publication)

MW 384.6 Da, Purity >98%. VDR activator. Induces cell differentiation and shows antiproliferative effects. Metabolic calcifediol (ab142766) precursor. Shows antioxidant and anti-inflammatory effects in vivo. Orally active.
1 Images
Chemical Structure - Cholecalciferol (Vitamin D3), VDR activator (AB143594)
  • Chemical Structure

Lab

Chemical Structure - Cholecalciferol (Vitamin D3), VDR activator (AB143594)

2D chemical structure image of ab143594, Cholecalciferol (Vitamin D3), VDR activator

Key facts

CAS number

67-97-0

Purity

>98%

Form

Solid

form

Molecular weight

384.6 Da

Molecular formula

C<sub>2</sub><sub>7</sub>H<sub>4</sub><sub>4</sub>O

PubChem

5280795

Nature

Synthetic

Solubility

Soluble in ethanol

Soluble in DMSO

Biochemical name

Cholecalciferol

Biological description

VDR activator. Induces cell differentiation and shows antiproliferative effects. Metabolic calcifediol (ab142766) precursor. Shows antioxidant and anti-inflammatory effects in vivo. Orally active.

Canonical smiles

CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C

Isomeric smiles

C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C

InChi

InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1

InChiKey

QYSXJUFSXHHAJI-YRZJJWOYSA-N

IUPAC Name

(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The alpha 1 Glycine Receptor (GLRA1) and Vitamin D Receptor (VDR) have distinct roles yet some interconnected pathways. GLRA1 often known as the glycine receptor is a ligand-gated ion channel found in the central nervous system. This receptor with a mass of approximately 48 kDa facilitates fast synaptic transmission by allowing chloride ions to pass through the cell membrane leading to inhibitory neurotransmission. In contrast the Vitamin D Receptor primarily a nuclear receptor belongs to the NR1I1 family and functions in regulating gene expression. The VDR is expressed in various tissues including intestine bone brain and immune cells.
Biological function summary

The alpha 1 Glycine Receptor contributes to the control of motor and sensory processing. It forms part of a pentameric complex in conjunction with other glycine receptor subunits to exert its inhibitory effect on neuronal transmission. The Vitamin D Receptor on the other hand plays a regulatory role in calcium and phosphate homeostasis and bone mineralization. This receptor mediates the effects of 125-dihydroxyvitamin D3 the active form of vitamin D by binding it and facilitating its action on gene transcription for various biological processes.

Pathways

Several actions of the alpha 1 Glycine Receptor impact the inhibition pathway related to neuronal signaling involving proteins such as gephyrin which stabilizes receptor clustering. The Vitamin D Receptor is important in the calcium signaling pathway and works closely with parathyroid hormone. These pathways further integrate into broader regulatory mechanisms affecting homeostasis and cellular response.

Mutations in the GLRA1 gene can lead to neurological conditions like hyperekplexia also known as startle disease where its improper function alters inhibitory control. The Vitamin D Receptor links to disorders like osteoporosis due to its role in bone density regulation; its interaction with other nuclear receptors such as the retinoid X receptor affects bone homeostasis. Understanding these targets helps in unraveling the complexities of neuronal and metabolic disorders.

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Tissue engineering. Part C, Methods 28:335-350 PubMed35323028

2022

Cholecalciferol as Bioactive Plasticizer of High Molecular Weight Poly(D,L-Lactic Acid) Scaffolds for Bone Regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Andrea Roberto Calore,Darya Hadavi,Maarten Honing,Ane Albillos-Sanchez,Carlos Mota,Katrien Bernaerts,Jules Harings,Lorenzo Moroni
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com